Abstract
Background
Treatment outcome was evaluated in patients who underwent breast-conserving therapy and tangential irradiation. After verifying background factors including systemic therapy, the clinical efficacy of postoperative irradiation was investigated.
Method
There were 708 study subjects, all of whom had early breast cancer treated between 1992 and 2002. The median follow-up period was 83 months. After breast-conserving surgery, in patients with negative surgical margins, only tangential irradiation at 48 Gy/24 fr was performed. In contrast, in those with positive surgical margins, 10 Gy of radiation boost to the tumor bed with electrons was administered after tangential irradiation with 50 Gy/25 fr. Treatment outcome was analyzed using the Kaplan–Meier method and Cox’s proportional hazards regression model.
Results
The disease-free survival and no-recurrence rates within the ipsilateral breast after 5 years were 93.4 and 97.2%, respectively. Risk factors for recurrence within the ipsilateral breast included younger age of patient, the number of positive lymph nodes, and no endocrine therapy. However, the surgical margin was not a risk factor. Risk factors for relapse outwith the ipsilateral breast included younger age, the number of positive lymph nodes, and recurrence within the ipsilateral breast.
Conclusions
From our analysis of 708 Japanese women who received breast-conserving therapy, which can be regarded as a standard method in Japan, the treatment outcome was compatible with previous reports from other countries.
Similar content being viewed by others
Abbreviations
- NRRB:
-
No recurrence rate within ipsilateral breast
- DFSR:
-
Disease-free survival rate
- y.o:
-
Years old
- fr:
-
Fraction
- Tm:
-
Tumorectomy
- Bp:
-
Wide excision
- Bq:
-
Quadrantectomy
- RTP:
-
Radiation treatment planning device
- SC-irradiation:
-
Irradiation to the ipsilateral supraclavicular nodal region
- ER:
-
Estrogen receptor
- PgR:
-
Progesterone receptor
- K–M method:
-
The Kaplan–Meier method
References
Moriguchi Y, Mise K, Kan N, Yamabe H, Hiraoka M, Kodama H. Long-term results of breast-conserving therapy (BCT) with special reference to ipsilateral breast tumor recurrence at Kodama Breast Clinic. Nyuugan no Rinsyou. 2006;21:159–64. in Japanese with English abstract.
Part 3. Nyuusen syuyou no soshiki-gaku-teki-bunrui. In: The Japanese Breast Cancer Society editor. General rules for clinical and pathological recording of breast cancer. 15th ed. Kanehara Syuppan, Tokyo; 2004. pp 31–68.
Ohkawa T, Kodama H, Akiyama H, Itou Y, Inaji H, Ohuchi N, et al. Nyuubou-Onzonryouhou Gaidorain (1999). Nyuugan no Rinsyou. 2000;15:147–56. in Japanese.
Noh WC, Paik NS, Kim MS, Yang KM, Cho CK, Choi DW, et al. Ipsilateral breast tumor recurrence after breast-conserving therapy: a comparison of quadrantectomy versus lumpectomy at single institution. World J Surg. 2005;29:1001–6.
Arriagada R, Lê MG, Contesso G, Guinebretière JM, Rochard F, Spielmann M. Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol. 2002;13:1404–13.
Kodaira T, Fuwa N, Itho Y, Matsumoto A, Kamata M, Furutani K, Sasaoka M, Miura S, Takeuchi T. Aichi Cancer Center 10-year experience with conservative breast treatment of early breast cancer: retrospective analysis regarding failure pattern and factors influencing local control. Int J Radiat Oncol Biol Phys 2001;49:1311–6.
Leong C, Boyages J, Jayasinghe UW, Bilous M, Ung O, Chua B, et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast cancer. Cancer. 2004;100:1823–32.
Jobsen JJ, van der Palen J, Ong F, Meerwaldt JH. The value of a positive margin for invasive carcinoma in breast-conservative treatment in relation to local recurrence is limited to young women only. Int J Radiat Oncol Biol Phys 2003;57:724–31.
Schnitt SJ, Abner A, Gelman R, Connolly JL, Recht A, Duda RB, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast conserving therapy. Cancer. 1994;74:1746–51.
Gage I, Schnitt SJ, Nixon AJ, Silver B, Recht A, Troyan SL, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer. 1996;78:1921–8.
Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999;44:1005–15.
Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000;18:1668–75.
Obedian E, Haffty BG. Negative margin status improves local control in conservatively managed breast cancer patients. Cancer J Sci Am 2000;6:28–33.
Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001;345:1378–87.
Jhingran A, Kim JS, Buchholz TA, Katz A, Strom EA, Hunt KK, et al. Age as a predictor of outcome for women with DCIS treated with breast-conservating surgery and radiation: The University of Texas M.D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 2002;53:868–79.
Polgar C, Fodor J, Orosz Z, Major T, Takácsi-Nagy Z, Mangel LC, et al. Electron and high-dose-rate brachytherapy boost in the conserving treatment of satge I–II breast cancer: first results of the randomized Gudapest boost trail. Strahlen Onkol. 2002;178:615–23.
Frazier TG, Wong RW, Rose D. Implications of accurate pathologic margins in the treatment of primary breast cancer. Arch Surg 1989;124:37–8.
Horiguchi J, Iino Y, Takei H, Maemura M, Yokoe T, Niibe H, et al. Surgical margin and breast recurrence after breast-conserving therapy. Oncol Rep 1999;6:135–8.
Fisher B, Bryant J, Dignam JJ, Wickerham DL, Mamounas EP, Fisher ER, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancer of one centimeter or less. J Clin Oncol. 2002;20:4141–9.
Vujovic O, Yu E, Cherian A, Dar AR, Stitt L, Perera F. Eleven-year follow-up in the delay of breast irradiation after conservative breast surgery in node-negative breast cancer patients. Int J Radiat Oncol Biol Phys. 2006;64(3):760–4.
Vujovic O, Cherian A, Yu E, Dar AR, Stitt L, Perera F. The effect of timing of radiotherapy after breast-conserving surgery in patients with positive or close resection margin, young age, and node-negative disease, with long term follow-up. Int J Radiat Oncol Biol Phys. 2006;66:687–90.
Inaji H, Akiyama F, Iino Y, Iino Y, Ikeda T, Ohsumi S, Tanaka AS, Kinoshita T, Murakami S. 13-9 Cyouki no tsuiseki kekka ni motozuku nyuugan ni taisuru tekiseina nyuubou onzon ryouho no kakuritu ni kansuru kenkyuu. Kouseiroudousyhou Gan-kenkyu-jyosei-kin niyoru kenkyu houkoku syu Heisei 13nen 402–406, 2001 (in Japanese).
Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trial. Lancet. 2005;366:2087–106.
Vinh-Hung V, Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst. 2004;96:115–21.
Acknowledgments
We thank Fumio Sakauchi MD. Ph.D. (Department of Public Health, Sapporo Medical University School of Medicine) for advice on statistical analysis.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Oouchi, A., Sakata, Ki., Masuoka, H. et al. The treatment outcome of patients undergoing breast-conserving therapy: the clinical role of postoperative radiotherapy. Breast Cancer 16, 49–57 (2009). https://doi.org/10.1007/s12282-008-0079-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12282-008-0079-3